N-acetylcysteine for COPD: the evidence remains inconclusive

Lancet Respir Med. 2014 Apr;2(4):e3. doi: 10.1016/S2213-2600(14)70054-2.

Authors

Richard D Turner¹, Graham H Bothamley²

Affiliations

¹ Department of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, Homerton Row, London E9 6SR, UK. Electronic address: richard.turner@homerton.nhs.uk.
² Department of Respiratory Medicine, Homerton University Hospital NHS Foundation Trust, Homerton Row, London E9 6SR, UK.

PMID: 24717631
DOI: 10.1016/S2213-2600(14)70054-2

No abstract available

Publication types

Letter
Comment

MeSH terms

Acetylcysteine / administration & dosage*
Female
Free Radical Scavengers / administration & dosage*
Humans
Male
Pulmonary Disease, Chronic Obstructive / complications*
Pulmonary Disease, Chronic Obstructive / drug therapy*

Substances

Free Radical Scavengers
Acetylcysteine